Dimethyltryptamine molecule:

Image from PubChem

DMT Clinical Trials


A Phase 1 Dose-ranging Study of GH001 in Healthy Volunteers


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04640831

Organisation Name: GH Research Limited

Overal Status: Completed

Start Date: March 13, 2019

Last Update: November 23, 2020

Lead Sponsor: GH Research Limited

Brief Summary: The aim of the study is to investigate the safety of GH001 (containing 5-methoxy-dimethyltryptamine; 5-MeO-DMT), and its dose-related psychoactive effects in healthy volunteers.

The study will evaluate single, ascending doses of GH001 in Part A and an individualized dosing regimen of GH001 in Part B.

Conditions:
  • Healthy Volunteers


Total execution time in seconds: 0.29907989501953